AC
REPL icon

AXQ Capital’s Replimune Group REPL Stock Holding History

AXQ Capital’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$199K Buy
26,065
+6,203
+31% +$47.4K 0.03% 752
2025
Q4 		$193K Buy
+19,862
New +$169K 0.04% 579
2025
Q2 		– Sell
-12,191
Closed -$119K – 744
2025
Q1 		$119K Buy
+12,191
New +$151K 0.05% 434

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AXQ Capital's REPL Position: Q1 2026 in Review

AXQ Capital increased its Replimune Group (REPL) stake by 31% in Q1 2026, buying an estimated $47.4K and bringing the position to 26,065 shares worth $199K. The position accounts for 0.03% of the portfolio, ranked #752.

AXQ Capital first reported a position in REPL in Q1 2025 and has held it in 3 quarters since. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • AXQ Capital held 26,065 shares of Replimune Group worth $199K as of Q1 2026.
  • AXQ Capital bought 6,203 Replimune Group shares in Q1 2026, an estimated $47.4K.
  • Replimune Group made up 0.03% of AXQ Capital's portfolio in Q1 2026, its #752 holding.
  • AXQ Capital first reported a position in Replimune Group in Q1 2025 and has held it in 3 quarters since.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.